Medical & Surgical Robots in 2026
7 trackedMedical robots split into two families: surgical platforms that extend a surgeon's precision in soft-tissue and orthopedic procedures, and hospital service robots that haul supplies and medications. This is the highest-value, most regulated sector — install bases and FDA clearances tell the real story.
Surgical robotics exceeds $10B annually; Intuitive's installed base reached 11,710 da Vinci systems worldwide, of which 1,700+ are the current da Vinci 5 generation.
Leaderboard
How we rank →| # | Robot | Maker | Status | Price | Index score |
|---|---|---|---|---|---|
| 1 | HYDROS Robotic System | PROCEPT BioRobotics | Commercial | $495,000 | 89.5 |
| 2 | Mako SmartRobotics | Stryker | Commercial | — | 85.6 |
| 3 | da Vinci 5 | Intuitive Surgical | Commercial | — | 83.9 |
| 4 | Hugo RAS | Medtronic | Commercial | — | 83.4 |
| 5 | Moxi | Diligent Robotics | Commercial | — | 82.2 |
| 6 | Ottava | Johnson & Johnson MedTech | Limited deployment | — | 72.3 |
| 7 | Versius / Versius Plus | CMR Surgical | Commercial | — | 68.5 |
Status breakdown
- Commercial
- 6 robots
- Limited deployment
- 1 robot
Hospital capital equipment; systems reported at $1–2.5M plus per-procedure consumables.
Latest in medical
- Moxi — Moxi 2.0 rollout begins at Endeavor Health Edward Hospital and Children's Hospital Los Angeles
- HYDROS Robotic System — Q2 2026 results: $94.5M revenue, 65 US systems delivered, 13,100+ US procedures
- Ottava — FDA grants De Novo marketing authorization for ten general surgery procedures
- da Vinci 5 — Q2 2026: installed base reaches 11,710 systems; 246 da Vinci 5 placed in the quarter
- Hugo RAS — Medtronic submits 510(k) filings to expand Hugo into general and gynecologic surgery in the US
- HYDROS Robotic System — International launch of the HYDROS Robotic System announced
- Versius / Versius Plus — CMR kicks off Versius Plus US commercial launch alongside the SAGES annual meeting
- Moxi — Serve Robotics agrees to acquire Diligent Robotics (~$29M stock plus up to $5.3M milestones)
Popular comparisons
Medical & Surgical Robots: common questions
What is the leading surgical robot in 2026?
Intuitive's da Vinci 5 leads soft-tissue surgery by installed base and procedure volume by a wide margin. Stryker's Mako leads orthopedics, Medtronic's Hugo and CMR's Versius compete internationally on cost and modularity, and Johnson & Johnson's Ottava received FDA De Novo authorization in July 2026 for an initial set of general-surgery procedures. Our leaderboard ranks platforms by deployment scale and traction — not clinical outcomes.
How much does a surgical robot cost?
Media and analyst reports put flagship soft-tissue systems at roughly $1–2.5M per unit — da Vinci 5 is reported around $2M — plus recurring instrument and service revenue per procedure. Focused single-indication platforms cost less: Procept's HYDROS is reported at about $495,000. Manufacturers do not publish list prices; hospitals negotiate.
Is robotic surgery better than traditional surgery?
That is a clinical question outside this site's scope. Robotic platforms offer documented advantages in precision, tremor filtration and minimally invasive access for many procedures; outcomes depend on the procedure and the surgeon. We track the platforms, not clinical superiority claims — always consult clinicians and peer-reviewed evidence.
Alert me on medical robot news
New announcements, deployments and price changes in the medical & surgical robots sector.